Determination of urea kinetics by isotope dilution with [C-13]urea and gas chromatography isotope ratio mass spectrometry (GC-IRMS) analysis

被引:21
作者
Kloppenburg, WD
Wolthers, BG
Stellaard, F
Elzinga, H
Tepper, T
deJong, PE
Huisman, RM
机构
[1] DEPT INTERNAL MED, DIV NEPHROL, NL-9700 RB GRONINGEN, NETHERLANDS
[2] UNIV GRONINGEN HOSP, CENT LAB CLIN CHEM, NL-9700 RB GRONINGEN, NETHERLANDS
[3] UNIV GRONINGEN HOSP, GRONINGEN INST DRUG STUDIES, DEPT PEDIAT, LAB NUTR & METAB, NL-9700 RB GRONINGEN, NETHERLANDS
关键词
gas chromatography isotope ratio MS; stable isotopes; ureamia; urea dilution;
D O I
10.1042/cs0930073
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Stable urea isotopes can be used to study urea kinetics in humans, The use of stable urea isotopes far studying urea kinetic parameters in humans on a large scale is hampered by the high costs of the labelled material, We devised a urea dilution for measurement of the distribution volume, production rate and clearance of urea in healthy subjects and renal failure patients using the inexpensive single labelled [C-13]urea isotope with subsequent analysis by headspace chromatography-isotope ratio MS (GC-IRMS) of the [C-13]urea enrichment, 2. The method involves measurement of the molar percentage excess of [C-13]urea in plasma samples taken over a 4 h period after an intravenous bolus injection of [C-13]urea, During the sample processing procedure, the plasma samples together with calibration samples containing a known molar percentage excess of [C-13]urea are acidified with phosphoric acid to remove endogenous CO2, and are subsequently incubated with urease to convert the urea present in the plasma samples into CO2. The C-13 enrichment of the generated CO2 is analysed by means of GC-IRMS, This method allows measurement of the molar percentage excess of [C-13]urea to an accuracy of 0.02%. 3. Reproducibility studies showed that the sample processing procedure [within-run coefficient of variation (CV) <2.8% and between-run CV <8.8%] and the GC-IRMS analysis (within-day CV <1.3% and between-day CV <1.3%) could be repeated with good reproducibility, 4. In clinical urea kinetic studies in a healthy subject and in a renal failure patient without residual renal function, reproducible values of the distribution volume, production rate and clearance of urea were determined using minimal amounts of [C-13]urea (25-50 mg). 5. because only low [C-13]urea enrichments are needed in this urea dilution method using GC-IRMS analysis, the costs of urea kinetic studies are reduced considerably, especially in patients with renal failure.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 16 条
[1]   MEASUREMENT OF (C-13) ARGININE INCORPORATION INTO APOLIPOPROTEIN B-100 IN VERY LOW-DENSITY LIPOPROTEINS AND LOW-DENSITY LIPOPROTEINS IN NORMAL SUBJECTS USING (C-13) SODIUM-BICARBONATE INFUSION AND ISOTOPE RATIO MASS-SPECTROMETRY [J].
BENNETT, MJ ;
CRYER, DR ;
YUDKOFF, M ;
COATES, PM ;
CORTNER, JA ;
MARSH, JB .
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1990, 19 (08) :459-464
[2]   UREA AND DEUTERIUM-OXIDE SPACES IN MAN [J].
BRADBURY, MW .
BRITISH JOURNAL OF NUTRITION, 1961, 15 (02) :177-+
[4]   REFINING THE MODEL OF UREA KINETICS - COMPARTMENT EFFECTS [J].
DEPNER, TA .
SEMINARS IN DIALYSIS, 1992, 5 (02) :147-154
[5]   ASSESSING ADEQUACY OF HEMODIALYSIS - UREA MODELING [J].
DEPNER, TA .
KIDNEY INTERNATIONAL, 1994, 45 (05) :1522-1535
[6]  
Eisenman AJ, 1936, J BIOL CHEM, V116, P33
[7]  
HOFFER LJ, 1988, MODERN NUTRITION HLT, P774
[8]   SIMULTANEOUS ANALYSIS OF INSULIN AND N-15(2)-UREA KINETICS IN HUMANS [J].
ODEH, YK ;
WANG, Z ;
RUO, TI ;
WANG, T ;
FREDERIKSEN, MC ;
POSPISIL, PA ;
ATKINSON, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (04) :419-425
[9]  
PEARSON P, 1994, J AM SOC NEPHROL, V4, P1869
[10]  
PIETRO AS, 1953, J BIOL CHEM, V201, P445